RecruitingNCT05444283
Genomic Predictors of Recurrent Pregnancy Loss
Large Scale Genome Sequencing and Integrative Analyses to Define Genomic Predictors of Recurrent Pregnancy Loss
Sponsor
Yale University
Enrollment
500 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with recurrent pregnancy loss. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years to 50 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05444283
Related Trials
Right Prefrontal Autonomic Mapping in Recurrent Pregnancy Loss With Comorbid Anxiety
NCT069680263 locations
Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss
NCT073253702 locations
Tender Loving Care for Recurrent Pregnancy Loss
NCT061828781 location
Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
NCT051695411 location
Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab
NCT066521132 locations